share_log

Stifel Upgrades Black Diamond Therapeutic to Buy, Raises Price Target to $10

Benzinga ·  Jun 30, 2023 04:45

Stifel analyst Bradley Canino upgrades Black Diamond Therapeutic (NASDAQ:BDTX) from Hold to Buy and raises the price target from $2 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment